Ignite Creation Date:
2024-05-06 @ 2:30 AM
Last Modification Date:
2024-10-26 @ 11:18 AM
Study NCT ID:
NCT02050529
Status:
COMPLETED
Last Update Posted:
2018-10-26
First Post:
2014-01-29
Brief Title:
Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients
Sponsor:
Dow University of Health Sciences
Organization:
Dow University of Health Sciences
Organization Data
Organization:
Dow University of Health Sciences
Class:
OTHER
Study ID:
Labetalol in Severe preg HTN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dow University of Health Sciences
Lead Sponsor Class:
OTHER
Responsible Party:
Saima Aziz Siddiqui
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dow University of Health Sciences
Old Name:
None
Old Organization:
None